Presentation is loading. Please wait.

Presentation is loading. Please wait.

Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis  Mariette Baud, MD, Salvatore Strano, MD, PhD, Agnes.

Published byἌμπελιος Παπαφιλίππου Modified over 5 years ago

Similar presentations

Presentation on theme: "Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis  Mariette Baud, MD, Salvatore Strano, MD, PhD, Agnes."— Presentation transcript:

1 Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis 
Mariette Baud, MD, Salvatore Strano, MD, PhD, Agnes Dechartres, MD, Rami Jouni, MD, Frederic Triponez, MD, PhD, Christos Chouaid, MD, PhD, Patricia Forgez, PhD, Diane Damotte, MD, PhD, Nicolas Roche, MD, PhD, Jean-François Régnard, MD, Marco Alifano, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 145, Issue 5, Pages (May 2013) DOI: /j.jtcvs Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Flow diagram of patients. MPM, Malignant pleural mesothelioma. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 A, Kaplan-Meier overall survival of the whole population. B, Kaplan-Meier overall survival with respect to gender. C, Kaplan-Meier overall survival with respect to asbestos exposure. D, Kaplan-Meier overall survival with respect to American Society of Anesthesiologists (ASA) class. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 A, Kaplan-Meier overall survival with respect to histologic type. B, Kaplan-Meier overall survival with respect to blood leukocyte count. C and D, Kaplan-Meier overall survival with respect to C-reactive protein (CRP) levels.WBC, White blood cells. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis  Mariette Baud, MD, Salvatore Strano, MD, PhD, Agnes."

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 

Manuel J. Antunes, MD, PhD, DSc 
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Mitral stenosis with pulmonary hypertension: We should operate early

Mitral stenosis with pulmonary hypertension: We should operate early
Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E

Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E
Christine Jablonski, M. D. , Marco Alifano, M. D

Christine Jablonski, M. D. , Marco Alifano, M. D
Preresection serum C-reactive protein measurement and survival among patients with resectable non–small cell lung cancer  Marco Alifano, MD, PhD, Pierre.

Preresection serum C-reactive protein measurement and survival among patients with resectable non–small cell lung cancer  Marco Alifano, MD, PhD, Pierre.
Which patients should be operated on after induction chemotherapy for N2 non–small cell lung cancer? Analysis of a 7-year experience in 175 patients 

Which patients should be operated on after induction chemotherapy for N2 non–small cell lung cancer? Analysis of a 7-year experience in 175 patients 
Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.
Lobectomy with pulmonary artery resection: Morbidity, mortality, and long-term survival  Marco Alifano, MD, Giacomo Cusumano, MD, Salvatore Strano, MD,

Lobectomy with pulmonary artery resection: Morbidity, mortality, and long-term survival  Marco Alifano, MD, Giacomo Cusumano, MD, Salvatore Strano, MD,
Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer  Remi Hervochon, MD, Antonio Bobbio, MD, PhD, Claude.

Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer  Remi Hervochon, MD, Antonio Bobbio, MD, PhD, Claude.
John E. Pilling, FRCS (CTh), Michael E

John E. Pilling, FRCS (CTh), Michael E
Intrinsic cardiac stem cells are essential for regeneration

Intrinsic cardiac stem cells are essential for regeneration
Victor van Berkel, MD, PhD 

Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 

William M. DeCampli, MD, PhD 
Multilevel data analysis: What? Why? How?

Multilevel data analysis: What? Why? How?
Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort  Leah Backhus, MD, Jonathon Sargent, BS, Aaron.

Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort  Leah Backhus, MD, Jonathon Sargent, BS, Aaron.
How should we treat air leaks?

How should we treat air leaks?
Go on-pump or off-pump in diabetic patients?

Go on-pump or off-pump in diabetic patients?
What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice  Tom.

What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice  Tom.

Similar presentations

Ads by Google